Literature DB >> 20578897

The genetics of the thyroid stimulating hormone receptor: history and relevance.

Terry F Davies1, Xiaoming Yin, Rauf Latif.   

Abstract

BACKGROUND: The thyroid stimulating hormone receptor (TSHR) is the key regulator of thyrocyte function. The gene for the TSHR on chromosome 14q31 has been implicated as coding for the major autoantigen in the autoimmune hyperthyroidism of Graves' disease (GD) to which T cells and autoantibodies are directed.
SUMMARY: The TSHR is a seven-transmembrane domain receptor that undergoes complex posttranslational processing. In this brief review, we look at the genetics of this important autoantigen and its influence on a variety of tissue functions in addition to its role in the induction of GD.
CONCLUSIONS: There is convincing evidence that the TSH receptor gene confers increased susceptibility for GD, but not Hashimoto's thyroiditis. GD is associated with polymorphisms in the intron 1 gene region. How such noncoding nucleotide changes influence disease susceptibility remains uncertain, but is likely to involve TSHR splicing variants and/or microRNAs arising from this gene region. Whether such influences are confined to the thyroid gland or whether they influence cell function in the many extrathyroidal sites of TSHR expression remains unknown.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578897      PMCID: PMC2935345          DOI: 10.1089/thy.2010.1638

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  88 in total

1.  Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease.

Authors:  Xiaoming Yin; Rauf Latif; Yaron Tomer; Terry F Davies
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

2.  Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity.

Authors:  Tayfun Ozcelik; Elif Uz; Cemaliye B Akyerli; Sevgi Bagislar; Chigdem A Mustafa; Alptekin Gursoy; Nurten Akarsu; Gokce Toruner; Nuri Kamel; Sevim Gullu
Journal:  Eur J Hum Genet       Date:  2006-06       Impact factor: 4.246

3.  Association of the TSHR gene with Graves' disease: the first disease specific locus.

Authors:  Bryan M Dechairo; Delilah Zabaneh; Joanne Collins; Oliver Brand; Gary J Dawson; Angie P Green; Ian Mackay; Jayne A Franklyn; John M Connell; John A H Wass; Wilmar M Wiersinga; Laszlo Hegedus; Thomas Brix; Bruce G Robinson; Penny J Hunt; Anthony P Weetman; Alisoun H Carey; Stephen C Gough
Journal:  Eur J Hum Genet       Date:  2005-11       Impact factor: 4.246

Review 4.  Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

Authors:  Terry F Davies; Takao Ando; Reigh-Yi Lin; Yaron Tomer; Rauf Latif
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

5.  High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity.

Authors:  Thomas Heiberg Brix; Gun Peggy S Knudsen; Marianne Kristiansen; Kirsten Ohm Kyvik; Karen Helene Orstavik; Laszlo Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2005-08-16       Impact factor: 5.958

6.  Regulation of the germinal center response by microRNA-155.

Authors:  To-Ha Thai; Dinis Pedro Calado; Stefano Casola; K Mark Ansel; Changchun Xiao; Yingzi Xue; Andrew Murphy; David Frendewey; David Valenzuela; Jeffery L Kutok; Marc Schmidt-Supprian; Nikolaus Rajewsky; George Yancopoulos; Anjana Rao; Klaus Rajewsky
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

7.  Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis.

Authors:  Yaron Tomer; Francesca Menconi; Terry F Davies; Giuseppe Barbesino; Roberto Rocchi; Aldo Pinchera; Erlinda Concepcion; David A Greenberg
Journal:  J Autoimmun       Date:  2007-07-20       Impact factor: 7.094

Review 8.  Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis.

Authors:  Fotini K Kavvoura; Takashi Akamizu; Takuya Awata; Yoshiyuki Ban; Dimitry A Chistiakov; Irena Frydecka; Abbas Ghaderi; Stephen C Gough; Yuji Hiromatsu; Rafal Ploski; Pei-Wen Wang; Yoshio Ban; Tomasz Bednarczuk; Emma I Chistiakova; Marcin Chojm; Joanne M Heward; Hitomi Hiratani; Suh-Hang Hank Juo; Lidia Karabon; Shigehiro Katayama; Susumu Kurihara; Rue-Tsuan Liu; Ikuyo Miyake; Gholam-Hossein R Omrani; Edyta Pawlak; Matsuo Taniyama; Teruaki Tozaki; John P A Ioannidis
Journal:  J Clin Endocrinol Metab       Date:  2007-05-15       Impact factor: 5.958

9.  Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody.

Authors:  Jane Sanders; Dimitri Y Chirgadze; Paul Sanders; Stuart Baker; Andrew Sullivan; Anshu Bhardwaja; Jane Bolton; Magnus Reeve; Nobuhiro Nakatake; Michele Evans; Tonya Richards; Michael Powell; Ricardo Núñez Miguel; Tom L Blundell; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Thyroid       Date:  2007-05       Impact factor: 6.568

10.  A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease.

Authors:  J C Taylor; S C Gough; P J Hunt; T H Brix; K Chatterjee; J M Connell; J A Franklyn; L Hegedus; B G Robinson; W M Wiersinga; J A H Wass; D Zabaneh; I Mackay; A P Weetman
Journal:  J Clin Endocrinol Metab       Date:  2005-11-08       Impact factor: 5.958

View more
  21 in total

1.  Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Authors:  Xiaoming Yin; Rauf Latif; Rebecca Bahn; Terry F Davies
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

2.  The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists.

Authors:  Erika E Englund; Susanne Neumann; Elena Eliseeva; Joshua G McCoy; Steven Titus; Wei Zheng; Noel Southall; Paul Shin; William Leister; Craig J Thomas; James Inglese; Christopher P Austin; Marvin C Gershengorn; Wenwei Huang
Journal:  Medchemcomm       Date:  2011-10       Impact factor: 3.597

3.  Maternal high-fat diet modulates the fetal thyroid axis and thyroid gene expression in a nonhuman primate model.

Authors:  Melissa A Suter; Haleh Sangi-Haghpeykar; Lori Showalter; Cynthia Shope; Min Hu; Kathleen Brown; Sarah Williams; R Alan Harris; Kevin L Grove; Robert H Lane; Kjersti M Aagaard
Journal:  Mol Endocrinol       Date:  2012-09-26

Review 4.  Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Michael R Zalutsky; Alexander S Sobolev
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 5.  Delineating the autoimmune mechanisms in Graves' disease.

Authors:  Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

6.  A Modifying Autoantigen in Graves' Disease.

Authors:  Rauf Latif; Mihaly Mezei; Syed A Morshed; Risheng Ma; Rachel Ehrlich; Terry F Davies
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

7.  TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.

Authors:  N E Bufalo; R B Dos Santos; M A Marcello; R P Piai; R Secolin; J H Romaldini; L S Ward
Journal:  J Endocrinol Invest       Date:  2014-12-28       Impact factor: 4.256

Review 8.  Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

Authors:  Terry F Davies; Rauf Latif
Journal:  Expert Opin Ther Targets       Date:  2015-03-13       Impact factor: 6.902

9.  Periostin silencing suppresses the aggressive phenotype of thyroid carcinoma cells by suppressing the Akt/thyroid stimulating hormone receptor axis.

Authors:  Min Wang; Chunyi Gui; Shenglong Qiu; Jingdong Tang; Zhihai Peng
Journal:  Cytotechnology       Date:  2017-09-30       Impact factor: 2.058

10.  Common genetic variants in pituitary-thyroid axis genes and the risk of differentiated thyroid cancer.

Authors:  Susana Pastor; Abdelmounaim Akdi; Eddy R González; Juan Castell; Josefina Biarnés; Ricard Marcos; Antonia Velázquez
Journal:  Endocr Connect       Date:  2012-10-10       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.